Gelatin as a delivery vehicle for the controlled release of bioactive molecules.
Gelatin is a commonly used natural polymer which is derived from collagen. The isoelectric point of gelatin can be modified during the fabrication process to yield either a negatively charged acidic gelatin, or a positively charged basic gelatin at physiological pH. This theoretically allows electrostatic interactions to take place between a charged biomolecule and gelatin of the opposite charge, forming polyion complexes. Various forms of gelatin carrier matrices can be fabricated for controlled-release studies, and characterization studies have been performed which show that gelatin carriers are able to sorb charged biomolecules such as proteins and plasmid DNA through polyion complexation. The crosslinking density of gelatin hydrogels has been shown to affect their degradation rate in vivo, and the rate of biomolecule release from gelatin carriers has been shown to have a similar profile, suggesting that complexed gelatin/biomolecule fragments are released by enzymatic degradation of the carrier in vivo. This review will emphasize how biomolecules released from gelatin controlled-release systems are able to retain their biological activity, allowing for their use in tissue engineering, therapeutic angiogenesis, gene therapy, and drug delivery applications.
Young
Simon
S
Department of Bioengineering, Rice University, Houston, TX 77251-1892, USA.
Wong
Mark
M
Tabata
Yasuhiko
Y
Mikos
Antonios G
AG
D000818:Animals; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D016503:Drug Delivery Systems; D004358:Drug Therapy; D005079:Excipients; D005780:Gelatin / Q000737:chemistry*; D015316:Genetic Therapy; D006801:Humans; D014677:Pharmaceutical Vehicles / Q000737:chemistry*; D023822:Tissue Engineering
D003692:Delayed-Action Preparations; D004337:Drug Carriers; D005079:Excipients; D014677:Pharmaceutical Vehicles; D005780:Gelatin